Physician profile
Derek Jones
NPI 1003897778
$1,720.40
in general payments reported to CMS, 2019-2025
15 companies · $572 in 2025
The $572 reported for 2025 was more than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $78.57 · 2021: $212 · 2022: $215 · 2023: $240 · 2024: $241 · 2025: $572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,001 · Education: $51.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,001.47 |
| Education | $51.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $466.45 | 2021-2025 | Dupixent |
| Genzyme Corporation | $339.85 | 2020-2025 | |
| Cochlear Americas | $209.86 | 2023-2025 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
| Intersect Ent, INC. | $158.65 | 2019-2021 | |
| Stryker Corporation | $139.69 | 2019-2022 | |
| Abbvie INC. | $93.10 | 2022 | |
| Medtronic, INC. | $89.31 | 2021-2025 | Propel |
| Glaxosmithkline, LLC. | $67.69 | 2022-2025 | Nucala |
| Amgen INC. | $34.00 | 2025 | |
| Hikma Pharmaceuticals USA | $28.66 | 2023 | Ryaltris |
| Optinose US, INC. | $24.51 | 2024 | |
| Aerin Medical INC. | $21.35 | 2019 | |
| Inspire Medical Systems, INC. | $19.98 | 2025 | Inspire |
| Paratek Pharmaceuticals, INC. | $16.50 | 2025 | Xhance |
| Galderma Laboratories, L.P. | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.